Determinations of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) activity in haploid strains and diploid hybrids of wild-type Saccharomyces cerevisiae revealed that a genetic basis exists for control of this key regulatory enzyme in which low enzyme activity is phenotypically dominant to high enzyme activity. These observations suggested the existence of an inhibitor of reductase activity or a suppressor of enzyme synthesis. Feeding studies using an early sterol intermediate (mevalonolactone) and end-product sterol (ergosterol) indicated that a secondary regulatory site in this pathway operates to decrease the activity of HMG-CoA reductase. This diminution of activity was paralleled by increases in the accumulation of squalene, suggesting that this intermediate (or another isoprenoid derivative) may also play a significant role in the in vivo regulation of sterol biosynthesis. Lastly, feedback inhibition of HMG-CoA reductase by ergosterol was demonstrated in a yeast mutant which is permeable to this sterol. These studies showed that yeast can serve as a eukaryotic model system for a combined biochemical and genetic investigation into the factors which control the activity of HMG-CoA reductase.
I N T R O D U C T I O N
The enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase, EC 1.1.1.34) functions as the primary regulatory site in the sterol biosynthetic pathway (Rodwell et al., 1976) . Current investigations into the factors which influence sterol formation and the regulation of HMG-CoA reductase in intact mammalian tissues and cultured cell systems have identified enzyme synthesis and degradation (Kleinsek et al., 1980; Beirne et al., 1977) and alterations in reductase activity possibly through' phosphorylationdephosphorylation (Ingebritsen et al., 1979) as the principal events involved in the regulation of this complex pathway. In recent years, several models have been proposed for the regulation of HMG-CoA reductase and each model has centred on specific cholesterol metabolites such as cholesteryl esters (Spence & Gaylor, 1977) and oxygenated cholesterol derivatives (Kandutsch et af., 1978) , or cholesterol precursors such as squalene (Brown & Goldstein, 1980) and lanosterol-like sterols (Have1 et al., 1980) . HMG-CoA reductase is also the rate-determining step in ergosterol biosynthesis in yeast (Kawaguchi, 1970; Quain & Haslam, 1979) and Kawaguchi (1970) has reported inhibition of HMG-CoA reductase activity by exogenous ergosterol in anaerobic yeast cultures. An increase in the squalene component was also noted during these feedback experiments. More recently, the conversion of squalene into sterols has been implicated as a highly regulated site in two reductase regulatory mutant strains of aerobically grown Saccharomyces cerevisiae (Downing et al., 1980) . These mutant strains, selected as resistant
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to the cytotoxic effects of the cholesterol analogue, 6-ketocholestanol, showed increases in the specific activity of HMG-CoA reductase that were paralleled by increases in the accumulation of squalene.
The present investigation establishes a yeast model system to study genetic and biochemical aspects of sterol regulation, and, in particular, the regulation of HMG-CoA reductase. The reductase activities in wild-type haploid and diploid cultures indicated that in hybrid diploids low levels of reductase activity and sterol production were dominant. This suggests that in yeast a genetic basis exists for limiting sterol synthesis by regulating HMGCoA reductase activity. In addition, a decrease in the specific activity of HMG-CoA reductase correlated with squalene accumulation during mevalonolactone and ergosterol feeding suggests that squalene (or another isoprenoid derivative) may function to affect the activity of this key regulatory enzyme. Lastly, ergosterol feeding was shown to result in feedback inhibition of HMG-CoA reductase.
M E T H O D S
Media. The medium used in these experiments contained 2 % (w/v) Difco Bacto-peptone, 1 % (w/v) Difco yeast extract, 5 % (w/v) glucose, plus 1 % (w/v) Tween 80 (a polyoxyethylene derivative of oleic acid). Exogenous ergosterol (0.5 mM) was dissolved in Tween 80 and this solution was added to the aqueous medium. After autoclaving, flasks were hand swirled for approximately 15 min to prevent precipitation of ergosterol during cooling. Mevalonolactone (7.6 mM) was added to the medium after autoclaving. All other chemicals and reagents were from Sigma.
Yeast strains. Strain ole3 is a porphyrin mutant that contains a lesion in the gene for Gaminolaevulinic acid synthase. Consequently, this organism cannot complete the terminal steps in ergosterol biosynthesis. Downing et al. (1980) recently described a mutant of ole3 which showed increased reductase activity and sterol production. This strain, R6K6, similarly cannot synthesize ergosterol. The particular isolate of strain ole3 utilized as the parent strain was originally derived from strain S288C; however, the ole3 strain was subsequently crossed and backcrossed between strains S288C-and asecond-wild-type strain, A 184D, in attempts to improve mating behaviour. The ole3 isolate used in this investigation is designated RW-2 and was provided by Dr R. A. Woods. With this diverse genetic background,the selection of ergosterol-synthesizing revertants of strains ole3' and R6K6 represented the isolation of two unique ergosterol-synthesizing strains (ole3-R and R6K6-R). Strains S288C and A184D are two commonly used wild-type haploid isolates of S. cereuisiae and have been previously used in sterol biosynthesis investigations (Woods et al., 1974) .
Growth conditions add HMG-CoA reductase assay. Cells were inoculated at an initial concentration of approximately lo5 cells ml-' and grown with shaking at 30 OC to late-exponential phase, as previously described (Downing et al., 1980) . Frozen cell pellets were thawed to room temperature and suspended to a density of 0.8 g ml-' in 100 mwpotassium phosphate buffer (pH 7.0) containing 1 mM-EDTA and 1 mM-dithiothreitol. An equivalent weight of pre-cooled glass beads (0.4-0-5 mm diam.) was added and the cells were disrupted in a Sorvall Omnimixer at 0 OC for 10 min. The suspension was then incubated in 0.5 % (v/v) Triton X-100 for 60 min at 0 OC. The fraction containing solubilized reductase was isolated and assayed as described by Quain & Haslam (1979) . A Pye Unicam model SP1750 spectrophotometer was used with a Haake constant temperature circulator (30 "C) to monitor the oxidation of NADPH at 340 nm.
Sterol analysis. The procedure for extracting the non-saponifiable fraction and quantifying the sterols present has been previously described (Woods et al., 1974; Downing et al., 1980) . Gas-liquid chromatographic analyses were performed on a Hewlett-Packard 57 10A gas chromatograph. Non-derivatized samples of the nonsaponifiable fraction were dried under nitrogen, taken up in heptane, and chromatographed on a glass column (1.83 m x 4 mm) containing 1 % (w/w) SE-30 on Gas-Chrom Q (80/100 mesh) at 240 "C. The carrier gas was nitrogen with a flow rate of 60ml min-I. Retention times were compared with those of authentic standards supplied by Dr Harold Pierce, Jr, Simon Fraser University. Sterols were quantified by weight determination of peak areas from original chromatograms.
R E S U L T S A N D D I S C U S S I O N
HMG-CoA reductase in haplotd.ahd diploid yeast Table 1 lists the specific activities of HMG-CoA reductase from the four haploid yeast strains and from specifically selected diploid hybrids. Also included is an analysis of the sterols synthesized in each strain examined. The haploid strain A 184D demonstrated an enzyme activity relative to strain S288C or ole3-R. $ Squalene and total sterol contents are expressed relative to those in strain S288C or ole3-R and are based on at least three separate determinations of sterol composition. Squalene and total sterols (underivatized) were quantified by weighing peak areas from gas-liquid chromatograms and determined as peak area per mg cell dry mass. Total sterols represent the combined peaks of zymosterol, ergosterol and 24(28)-dehydroergosterol.
approximately 2-fold increase in reductase activity relative to the haploid strain S288C. The expressed activity of HMG-CoA reductase which was characteristic of this haploid A 184D strain remained essentially unaltered when this strain was made diploid. The diploid hybrid S288C x A184D, however, showed a low HMG-CoA reductase activity which was characteristic of strain S288C. Examination of strains ole3-R and R6K6-R (selected as wild-type revertants of ole3 and R6K6, respectively) gave a similar result. While the reductase activity of the haploid strain R6K6-R was l.8-fold greater than the enzyme activity of haploid strain ole3-R, in the diploid strain formed by hybridizing these two strains, low reductase activity was again dominant to high enzyme activity. In these wild-type yeast strains, the major sterol products formed during exponential growth were zymosterol, ergosterol and 24(28)-dehydroergosterol. These compounds represented approximately 94 % of the total sterols synthesized. The observed changes of HMG-CoA reductase activity in the various haploid and diploid yeast strains were paralleled by similar alterations in the quantities of sterol products. Further investigations are necessary to determine whether this inhibition of activity is at the level of enzyme synthesis or the result of alterations in enzyme activity. Studies with mammalian cells have indicated that both mechanisms are significant during cholesterogenesis. Both the diurnal variation in reductase activity and the decrease in enzyme activity which follows cholesterol feeding result from an alteration in the synthesis of enzyme protein (Kleinsek et al., 1980; Shapiro & Rodwell, 1971) . Cytoplasmic inhibitors of HMG-CoA reductase activity have been found in rat liver cytosol, rat milk and pea seedlings (McNamara et al., 1972; Brooker & Russell, 1979) . However, the nature of the effector molecules and the mechanism of control remain unknown. Effect of mevalonolactone and ergosterol feeding on reductase activity HMG-CoA reductase catalyses the formation of mevalonic acid. Addition of this intermediate to growing mammalian cells has led to the identification of secondary regulatory sites in mammalian cholesterol biosynthesis due to the increased accumulation of distal metabolites. Specifically, mevalonate feeding experiments indicate that high concentrations of squalene and lanosterol accumulate in kidney, intestinal and lymphatic tissues, whereas cholesterol is the predominant product in the liver, thus suggesting tissue-specific regulation (Hellstrom et al., 1973) . Mevalonate feeding in mammalian tissue culture has implicated a * Ergosterol was added at a final concentration of 0.5 mM and mevalonolactone at 7.6 mM.
t Specific activities and standard deviations as in Table 1 . Numbers in parentheses indicate enzyme activity relative to strain ole3 or S288C growing in non-supplemented medium. $ Squalene and total sterol contents are expressed relative to those in strain ole3 or S288C growing in nonsupplemented medium, and are based on at least three separate determinations of sterol composition. Total sterols in strain ole3 represent the combined peaks of lanosterol, 4,14-dimethylzymosterol and 14-methylfecosterol; when ergosterol was included in the growth medium, total sterols also includes this sterol. Total sterols in strain S288C comprise the sterols listed in Table 1. number of compounds such as free cholesterol (Mitropoulos et al., 1978) , esterified cholesterol (Spence & Gaylor, 1977) , methylated sterol intermediates (Have1 et al., 1980) , and an unidentified squalene precursor (Brown & Goldstein, 1980) as important in feedback inhibition of HMG-CoA reductase.
A similar mechanism of HMG-CoA reductase regulation became apparent in haploid isolates of strains ole3 and S288C on the addition of sterol intermediates to the growth medium. Due to the absence of ergosterol synthesis in strain ole3, this strain remained permeable to exogenous sterols under aerobic conditions. Wild-type strains of S. cerevisiae (e.g. S288C) are impermeable to sterols under these conditions. Table 2 shows an analysis of sterol biosynthesis in strain ole3 grown in the presence of ergosterol or mevalonolactone and in strain S288C grown in the presence of mevalonolactone. In all three instances, the uptake of these sterol intermediates was accompanied by a decrease in the specific activity of HMG-CoA reductase. Ergosterol incorporation into strain ole3 resulted in a decrease in non-saponifiable sterols, a 4.5-fold increase in the cellular squalene content, and a 48 % decrease in reductase activity. Mevalonolactone incorporation into strain ole3 caused no change in the sterol content, a 3.5-fold increase in the accumulation of squalene, and a 43 % decrease in the activity of HMG-CoA reductase. In strain S288C, mevalonolactone feeding again had no effect on sterol content, but resulted in a 2-3-fold increase in the squalene component and a 32% decrease in reductase activity. These results suggest that in strains ole3 and S288C the total cellular sterol content is stringently regulated and that a sterol precursor (prior to squalene-2,3-epoxide) can depress the activity of HMG-CoA reductase.
Ergosterol feedback inhibition of reductase
Just as low density lipoprotein-mediated cholesterol uptake results in an inhibition of HMG-CoA reductase activity (Brown & Goldstein, 1978) , ergosterol feeding in yeast has a similar effect. It is interesting, however, that the normal physiological accumulation of ergosterol did not result in an inhibition of reductase activity. This can be shown by comparing HMG-CoA reductase activity in strains which are blocked in ergosterol biosynthesis with the wild-type strain. Strain ole3 does not synthesize ergosterol due to the block in porphyrin biosynthesis and only lanosterol and lanosterol-like intermediates are synthesized. When the strain was reverted to wild-type such that normal levels of ergosterol accumulated, HMG-CoA reductase activity was essentially the same (8.6 and 8-0, respectively, for ole3 and the revertant). However, ole3 is permeable to exogenous ergosterol and when grown in medium containing this sterol a significant decrease in HMG-CoA reductase was observed. These results suggesting feedback inhibition of HMG-CoA reductase by ergosterol confirm the observations of Kawaguchi (1970) but differ from the results of Trocha & Sprinson (1976) who found that HMG-CoA reductase activity was unresponsive to ergosterol supplementation. However, both investigations employed anaerobic cell conditions in which sterol synthesis is markedly decreased.
Thus, the results obtained in the present study provide evidence for (1) a genetic basis for the regulation of HMG-CoA reductase activity and sterol synthesis, (2) the regulation of squalene conversion into lanosterol, the first sterol in the biosynthetic pathway, and (3) feedback inhibition of HMG-CoA reductase by ergosterol feeding. Isolation of additional mutants and genetic analyses should contribute to an understanding of the number of genes and gene products involved in the regulation of sterol biosynthesis.
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